跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Lanzaph - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Lanzaph
Approved
STANDARD
Lanzaph
Sapphire Lifesciences Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
91a381e3f7eb1f6d
Company
Sapphire Lifesciences Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
91a381e3f7eb1f6d
Drug Approval Philippines Name
Lanzaph
Product Name
Lanzaph
Registration Number
DRP-13977
Brand Name
Lanzaph
Generic Name
Olanzapine
Dosage Form
Orally Disintegrating Tablet
Dosage Strength
10 mg
Manufacturer
Sapphire Lifesciences Pvt. Ltd.
Importer
Ollen Pharma Trading, Inc.
Distributor
Ollen Pharma Trading, Inc.
Issuance Date
29 May 2023
Expiry Date
29 May 2028
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
91a381e3f7eb1f6d
Type
Standard
Back to Philippines FDA Approvals